Ali S. Olyaei

Oregon Health & Science University

Affiliations

OHSU School of Medicine

Department Of Pediatrics

Division Of Physician Assistant Education

Department of Medicine

Division of Nephrology & Hypertension

Department Of Pediatrics

Division Of Nephrology

Oregon Health & Science University

NoneAli S. Olyaei is currently serving as a Pediatrics faculty at Oregon Health & Science University.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Ali S. Olyaei

Oregon Health & Science University

You can click a keyword to filter the displayed items

medicine clinical transplantation organ transplantation transplantation medicine hepatology transplant infectious diseases infectious diseases liver transplantation solid organ transplantation kidney transplantation nephrology immunology graft survival public health hematology clinical epidemiology transplantation proceeding antiviral therapy transplant surgery outcomes research clinical research medical virology antiviral research bone marrow transplantation clinical infectious disease immunosuppressive therapy cardiovascular disease respiratory medicine cell transplantation pharmacotherapy clinical microbiology graft rejection emerging infectious diseases viral hepatitis anticoagulants clinical infection cardiovascular research general virology virus research pediatric allergy medical mycology empirical case studies disease transmission disease outbreaks transplant arteriopathy antiviral drugs clinical allergy hypersensitivity drug allergy comparative analysis medical microbiology clinical mycology clinical guidance pancreas transplantation therapeutic efficacy stem cell transplantation bone marrow failure matching technique liver cancer viral oncology invasive fungal infection alliance registry invasive fungal infections transplant-specific risk factors cardiovascular events renal transplantation combination interferon polyethylene glycol american society expert consensus statement path alliance database cytomegalovirus serologic antibody-mediated rejection pancreas transplant recipient endocrine function pancreatic panniculitis pediatric urology pharmacology clinical biochemistry individualized medicine physiology translational research sepsis anesthesiology drug metabolism drug discovery intensive care health sciences critical care haematopoiesis translational medicine blood purification clinical investigation xenotransplantation medical education urology clinical trials personalized medicine laboratory medicine pediatric transplantation future medicinal chemistry pancreatitis alternative medicine applied pharmacology pharmaceutics internal medicine molecular pharmacology pharmacological research experimental medicine hypertension chronic kidney disease

Notable Scholarly Works

Notable Federal Grants

Collaborators

P-2108. Clinical Outcome Differences in Kidney Transplant Patients Receiving Letermovir Versus Valganciclovir for CMV Prophylaxis. Open Forum Infectious Diseases (2026)

Recurrence of Iga Nephropathy in a Kidney Transplant Patient Successfully Treated With Iptacopan—a Case Report. Frontiers in Immunology (2026)

immunologyimmunosuppressive therapymedicineorgan transplantationkidney transplantationnephrologyautoimmunityclinical transplantation

Access to Transplant and Recipient Outcomes Among Indigenous Patients: A Single-Center Study. American Journal of Transplantation (2025)

health equityindigenous patientsorgan transplantationtransplantation proceedingsingle-center studysolid organ transplantationfamily medicinetransplantation medicinerecipient outcomesglobal healthclinical transplantation

Current Status of CMV Prophylaxis Strategies, Viremia, Infection and Antiviral Side Effects, in Liver Transplant Recipients: Time for New Strategies? a Single-Center Retrospective Study. American Journal of Transplantation (2025)

hivmedicineorgan transplantationliver transplantationmedical virologyliver transplant recipientscmv prophylaxis strategiesepidemiologytransplant infectious diseasessolid organ transplantationhepatologyantiviral therapyinfectious diseasescurrent statusclinical transplantationinfectious diseases (medical specialty)

The Current Status of CMV Prophylaxis and Treatment in Liver Transplant Recipients: A Single Center Study. Journal of Liver Transplantation (2025)

medicineorgan transplantationliver transplantationcmv prophylaxisliver transplant recipientstransplant infectious diseasessolid organ transplantationtransplantation medicinehepatologyinfectious diseasescurrent statusclinical transplantationinfectious diseases (medical specialty)

Transplant Referral and Long-Term Kidney Allograft Survival for Black Patients: Single-Center Study. Journal of the American College of Surgeons (2025)

medicineblack patientsorgan transplantationtransplantation proceedingkidney transplantationtransplant referralsingle-center studynephrologyurologysolid organ transplantationafrican american studiesgraft survivalclinical transplantation

Toxic Nephropathies. (2022)

Expert Consensus Statement From the American Society of Echocardiography on Hypersensitivity Reactions to Ultrasound Enhancing Agents in Patients With Allergy to Polyethylene Glycol. Journal of the American Society of Echocardiography (2021)

Jonathan R. LindnerTodd BelcikMichael L. MainAnthony MontanaroSharon L. MulvaghJoan OlsonAli OlyaeiThomas R. PorterRoxy Senior

medicineclinical allergydrug allergypolyethylene glycolallergyamerican societyultrasoundexpert consensus statementpediatric allergyhypersensitivity

Graft-Versus-Host Disease After Liver Transplantation is Associated With Bone Marrow Failure, Hemophagocytosis, and Dnmt3A Mutations. American Journal of Transplantation (2021)

immunologymedicinegraft rejectionorgan transplantationliver transplantationhematologybone marrow failuregraft-versus-host diseasebone marrow transplantationhepatologycell transplantationpathologyclinical transplantationstem cell transplantation

Optimal Timing of Administration of Direct-Acting Antivirals for Patients With Hepatitis C-Associated Hepatocellular Carcinoma Undergoing Liver Transplantation. Annals of Surgery (2021)

Michael K. TurgeonShimul A. ShahAaron M. DelmanBenjamin V. TranVatche G. AgopianJoel P. WeddJoseph F. MaglioccaAhyoung KimAndrew CameronAli OlyaeiSusan L. OrloffMatthew P. AndersonChandrashekhar A. KubalRobert M. CannonJayme E. LockeMary A. SimpsonMohamed E. AkoadChelsey P. WongjiradJuliet EmamaulleeAmika MoroFederico AucejoCyrus A. FeizpourParsia A. VagefiMindie H. NguyenCarlos O. EsquivelKiran DhanireddyVijay SubramanianAlejandro ChavarriagaMarwan M. KazimiMaia S. AndersonChristopher J. SonnendaySteven C. KimDavid P. FoleyMarwan AbdouljoudReena J. SalgiaDimitrios MorisDebra L. SudanSwaytha R. GaneshAbhinav HumarMajella DoyleWilliam C. ChapmanShishir K. Maithel

surgerymedicineoptimal timingpharmacologyorgan transplantationliver transplantationliver cancersurgical oncologytransplant infectious diseasesvirologyoncologyhepatologyantiviral therapycancer treatmentdirect-acting antiviralshepatocellular carcinomaviral oncologytranslational medicine